Medical Laboratories stocks: intrinsic value, ROIC & growth
24 U.S. medical laboratories companies with at least three years of SEC filings, ranked by size. 3 of the 11 with a current price trade below their Graham intrinsic value. The median company earned a -8.2% average return on invested capital and grew revenue 25.9% a year.
Updated October 18, 2026
24companies
3below Graham value
-8.2%median 10-yr ROIC
25.9%median revenue CAGR
Highest-ROIC medical laboratories stocks
| Ticker | Company | 10-yr ROIC | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|---|
| GH | Guardant Health, Inc. | 24.6% | $158.60 | — | — | $19.9B | 24.6% | 50.2% |
| DGX | Quest Diagnostics | 11.9% | $235.00 | $179.52 | 31% above | $26.6B | 11.9% | 4.4% |
| FLGT | Fulgent Genetics, Inc. | 11.5% | $19.81 | $153.83 | 87% below | $609.7M | 11.5% | 37.6% |
| LH | Labcorp | 9.1% | $317.95 | $158.47 | 101% above | $26.6B | 9.1% | 4.2% |
| RDNT | RadNet, Inc. | 3.9% | $68.80 | $0.85 | 7994% above | $5.2B | 3.9% | 9.7% |
All medical laboratories stocks
| Ticker | Company | Price | Graham value | Price vs value | Market cap | ROIC (10y) | Revenue CAGR |
|---|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | $393.44 | — | — | $53.8B | -100.2% | 30.3% |
| LH | Labcorp | $317.95 | $158.47 | 101% above | $26.6B | 9.1% | 4.2% |
| DGX | Quest Diagnostics | $235.00 | $179.52 | 31% above | $26.6B | 11.9% | 4.4% |
| GH | Guardant Health, Inc. | $158.60 | — | — | $19.9B | 24.6% | 50.2% |
| RDNT | RadNet, Inc. | $68.80 | $0.85 | 7994% above | $5.2B | 3.9% | 9.7% |
| CAI | Caris Life Sciences, Inc. | $30.56 | — | — | $5.1B | 8.0% | 62.9% |
| GRAL | GRAIL, Inc. | $117.81 | — | — | $4.3B | -52.9% | 25.7% |
| VCYT | VERACYTE, INC. | $43.12 | $27.24 | 58% above | $3.5B | -38.0% | 25.9% |
| CDNA | CareDx, Inc. | $64.00 | $30.89 | 107% above | $3.4B | -49.5% | 28.2% |
| CELC | Celcuity Inc. | $56.58 | — | — | $2.6B | -1303.5% | — |
| BLLN | BillionToOne, Inc. | $98.12 | $4.65 | 2010% above | $2.1B | 13.4% | 106.2% |
| FTRE | Fortrea Holdings Inc. | $22.49 | $5.24 | 329% above | $2.0B | -8.2% | -2.9% |
| PSNL | Personalis, Inc. | $15.65 | — | — | $1.4B | -30.4% | 28.5% |
| CSTL | CASTLE BIOSCIENCES INC | $31.96 | $20.59 | 55% above | $926.4M | -32.1% | 47.4% |
| FLGT | Fulgent Genetics, Inc. | $19.81 | $153.83 | 87% below | $609.7M | 11.5% | 37.6% |
| RNLXY | Renalytix plc | $3.50 | $4.26 | 18% below | $378.6M | 329.7% | -12.2% |
| BDSX | BIODESIX INC | $23.66 | — | — | $178.7M | -248.1% | 23.8% |
| XGN | EXAGEN INC. | $7.72 | — | — | $166.4M | -142.8% | 10.8% |
| SERA | SERA PROGNOSTICS, INC. | $2.06 | — | — | $98.2M | -58.2% | 26.5% |
| ADVB | Advanced Biomed Inc. | $3.98 | — | — | $81.7M | 1242.0% | — |
| BGLC | BioNexus Gene Lab Corp | $1.20 | — | — | $21.4M | -15.0% | 66.2% |
| AMS | AMERICAN SHARED HOSPITAL SERVICES | $1.28 | $5.05 | 75% below | $8.5M | -0.9% | 4.6% |
| ACON | Aclarion, Inc. | $1.85 | — | — | $984.3K | -1213.6% | 5.9% |
| FCHS | First Choice Healthcare Solutions, Inc. | $0.01 | — | — | $263.7K | -7.5% | 7.6% |
Stock lists
Undervalued Stocks Below Graham Intrinsic Value
Highest ROIC Stocks (10-Year Average)
Highest Free Cash Flow Yield Stocks
Fastest-Growing Stocks by 10-Year Revenue